Search

• Heterotypic Ub reagents were obtained by CAET strategy with high efficiency. • The reagents identify heterotypic Ub-interacting and modifying proteins simultaneously. • Sequential release of two groups of proteins was completed by using urea and reductant. • Proteomic profiling facilitates future investigations of heterotypic Ub chains. Heterotypic ubiquitin (Ub) chains have emerged as fundamental components in a wide range of cellular processes. The integrative identification of Ub-interacting proteins (readers) and Ub-modifying enzymes (writers and erasers) that selectively recognize and regulate heterotypic ubiquitination may provide crucial insights into these processes. In this study, we employed the bifunctional molecule-assisted (CAET) strategy to develop a type of disulfide bond-activated heterotypic Ub reagents, which allowed to enrich heterotypic Ub-interacting proteins and modifying enzymes simultaneously. The sequential release of readers which are non-covalently bound and writers or erasers which are covalently conjugated by using urea and reductant, respectively, combined with label-free quantitative (LFQ) MS indicated that these heterotypic Ub reagents would facilitate future investigations into functional roles played by heterotypic Ub chains. [ABSTRACT FROM AUTHOR]

A higher diet quality has been associated with lower environmental impacts, but not consistently. Considering the cultural diversity of dietary habits and the heterogeneity of socioeconomic development in China, we aimed to evaluate the association between diet quality and environmental impacts across demographic subgroups and regions. This study used dietary consumption data from the China Health Nutrition Survey 2011. Diet quality was measured with the Chinese Healthy Eating Index 2016 (CHEI2016). Diet-related environmental impact (Greenhouse Gas Emissions (GHGE), Total Water Use (TWU), and Land Use (LU)) were estimated using the Chinese Food Life Cycle Assessment Database. Multilevel regression models were used to quantify the association of the CHEI2016 score and the diet-related environmental impacts across heterogeneous population subgroups. A one-standard deviation increase in CHEI2016 score was associated with an increase of 9.7% in GHGE, 9.1% in TWU, and 6.4% in LU. This occurs because increasing the consumption of under-consumed foods (dairy products and fruit), partially offsets the environmental benefits of reduced meat consumption. Demographic subgroups characterized by either higher educated or a higher income exhibited a larger proportion of animal-based foods within their diet, consequently leading to higher diet-related environmental impacts. When expressed per standard deviation increase in CHEI2016, the dietary environmental impacts rose fastest in the Metropolitan area and slowest in the Northeast. Diets with higher CHEI2016 scores are associated with higher diet-related environmental impacts among Chinese adults but this varies per region. The development of sustainable diet strategies needs to account for potential trade-off between the health and environmental goals, and dietary habits of consumers in different regions and subpopulations. [ABSTRACT FROM AUTHOR]

Sucralose and acesulfame-potassium consumption alters gut microbiota in rodents, with unclear effects in humans. We examined effects of three-times daily sucralose- and acesulfame-potassium-containing diet soda consumption for 1 (n = 17) or 8 (n = 8) weeks on gut microbiota composition in young adults. After 8 weeks of diet soda consumption, the relative abundance of Proteobacteria, specifically Enterobacteriaceae, increased; and, increased abundance of two Proteobacteria taxa was also observed after 1 week of diet soda consumption compared with sparkling water. In addition, three taxa in the Bacteroides genus increased following 1 week of diet soda consumption compared with sparkling water. The clinical relevance of these findings and effects of sucralose and acesulfame-potassium consumption on human gut microbiota warrant further investigation in larger studies. Clinical trial registration: NCT02877186 and NCT03125356. [ABSTRACT FROM AUTHOR]